US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Tempest Therpeutics Inc (TPST)
Tempest Therpeutics Inc (TPST) ニュース

TPST

Tempest Therpeutics (TPST)

Tempest Therpeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TPST

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/14	05 : 54	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TPST	Tempest Therpeutics Inc
2024/05/10	05 : 29	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TPST	Tempest Therpeutics Inc
2024/05/10	05 : 29	GlobeNewswire Inc.	Tempest Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:TPST	Tempest Therpeutics Inc
2024/05/10	05 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TPST	Tempest Therpeutics Inc
2024/04/27	05 : 05	GlobeNewswire Inc.	Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TPST	Tempest Therpeutics Inc
2024/04/09	21 : 00	GlobeNewswire Inc.	Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting	NASDAQ:TPST	Tempest Therpeutics Inc
2024/04/04	21 : 00	GlobeNewswire Inc.	Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications	NASDAQ:TPST	Tempest Therpeutics Inc
2024/03/20	05 : 25	GlobeNewswire Inc.	Tempest Reports Year End 2023 Financial Results and Provides Business Update	NASDAQ:TPST	Tempest Therpeutics Inc
2024/03/12	21 : 00	GlobeNewswire Inc.	Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types	NASDAQ:TPST	Tempest Therpeutics Inc
2024/03/06	06 : 30	GlobeNewswire Inc.	Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting	NASDAQ:TPST	Tempest Therpeutics Inc
2024/02/26	22 : 00	GlobeNewswire Inc.	Tempest to Present at the 44th Annual TD Cowen Healthcare Conference	NASDAQ:TPST	Tempest Therpeutics Inc
2024/02/15	08 : 49	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TPST	Tempest Therpeutics Inc
2024/02/15	04 : 12	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TPST	Tempest Therpeutics Inc
2024/02/09	07 : 41	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TPST	Tempest Therpeutics Inc
2024/02/03	06 : 30	GlobeNewswire Inc.	Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TPST	Tempest Therpeutics Inc
2024/01/06	06 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TPST	Tempest Therpeutics Inc
2024/01/06	06 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TPST	Tempest Therpeutics Inc
2024/01/06	06 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TPST	Tempest Therpeutics Inc
2024/01/06	06 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TPST	Tempest Therpeutics Inc
2024/01/06	06 : 05	GlobeNewswire Inc.	Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TPST	Tempest Therpeutics Inc
2023/12/02	06 : 15	GlobeNewswire Inc.	Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/20	22 : 00	GlobeNewswire Inc.	Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/18	06 : 46	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/18	06 : 45	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/18	06 : 44	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/18	06 : 44	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/18	06 : 43	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/18	06 : 39	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/10	07 : 28	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:TPST	Tempest Therpeutics Inc
2023/11/09	07 : 25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TPST	Tempest Therpeutics Inc

Showing the most relevant articles for your search:NASDAQ:TPST

1 2 3 4 5 6 7 次へ >>

Futebol Clube do Porto F...

Scalara NFT Index

BlackRock Institutional ...

Anhui Expressway (PK)

Banque Postalela null

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約